Journal articles on the topic 'Hormonal therapy (HT)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Hormonal therapy (HT).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Mainar, Laura Baquedano, Leyre Ruiz Campo, Alberto Lanzon Laga, and Miguel Angel Ruiz Conde. "Endometrial cancer and hormonal therapy (HT)." Maturitas 81, no. 1 (May 2015): 198. http://dx.doi.org/10.1016/j.maturitas.2015.02.286.
Full textMizowaki, T., Y. Norihisa, M. Ogura, T. Kamba, T. Inoue, Y. Shimizu, O. Ogawa, and M. Hiraoka. "Survival outcomes of neoadjuvant hormone therapy plus external-beam radiotherapy with relatively early initiation of salvage hormone therapy to patients with T3-4N0M0 prostate cancer." Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 95. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.95.
Full textWagner, Lynne I., Robert James Gray, George W. Sledge, Timothy Joseph Whelan, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, David Cella, and Joseph Sparano. "Patient-reported cognitive impairments among women with breast cancer randomly assigned to hormonal therapy (HT) alone versus chemotherapy followed by hormonal therapy (C+HT): Results from the Trial Assigning Individualized Options for Treatment (TAILORx)." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 9020. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9020.
Full textLam, Lydia, Kenji Inaba, Bernardino Castelo Branco, Bradley Putty, Ali Salim, Donald J. Green, Peep Talving, and Demetrios Demetriades. "The Impact of Early Hormonal Therapy in Catastrophic Brain-Injured Patients and Its Effect on Organ Procurement." American Surgeon 78, no. 3 (March 2012): 318–24. http://dx.doi.org/10.1177/000313481207800340.
Full textAizawa, Rihito, Kenji Takayama, Kiyonao Nakamura, Takahiro Inoue, Takashi Kobayashi, Shusuke Akamatsu, Toshinari Yamasaki, Osamu Ogawa, and Takashi Mizowaki. "Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with non-metastatic prostate cancer." Journal of Clinical Oncology 36, no. 6_suppl (February 20, 2018): 49. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.49.
Full textFlanagan, J. R., C. Carney-Doebbeling, L. Jones, and C. Sweeney. "Metabolic syndrome predicts for shorter response to hormonal therapy in prostate cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 4554. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4554.
Full textAberbach, Irit, Liliana Schliamser, Zeev Blumenfeld, Benjamin Brenner, and Galit Sarig. "Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy." Thrombosis and Haemostasis 96, no. 11 (2006): 578–83. http://dx.doi.org/10.1160/th06-05-0285.
Full textOlufade, Temitope O., Karen E. Skinner, Nicola Di Santo, Rahul A. Shenolikar, Mark Stephen Walker, and Lee Steven Schwartzberg. "Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12537-e12537. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12537.
Full textLin, Jenny J., Kathie-Ann P. Joseph, Kezhen Fei, Rebeca Franco, and Nina Bickell. "Adherence to hormone treatment for breast cancer and beliefs about treatment and screening." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e11004-e11004. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e11004.
Full textMilitello, Loredana, Paolo Carli, Vincenzo Di Lauro, Simon Spazzapan, Simona Scalone, Davide Lombardi, Alessandro Tuzi, et al. "Bevacizumab as maintenance therapy (mBev) in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e22149-e22149. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e22149.
Full textDavis, S. R., I. Dinatale, L. Rivera-Woll, and S. Davison. "Postmenopausal hormone therapy: from monkey glands to transdermal patches." Journal of Endocrinology 185, no. 2 (May 2005): 207–22. http://dx.doi.org/10.1677/joe.1.05847.
Full textAhmed, Mohamed E., Jack R. Andrews, Ayca Dundar, Masaya Jimbo, Vidhu B. Joshi, Giovanni Motterle, Jeffrey Karnes, et al. "Non-rising PSA disease progression on C-11 choline PET/CT imaging in patients receiving second generation hormone therapies (2nd-HT)." Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020): 144. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.144.
Full textNanda, Akash, Ming-Hui Chen, Brian Joseph Moran, Michelle H. Braccioforte, and Anthony Victor D'Amico. "Intermediate versus short-course hormone therapy and mortality in men with high-risk prostate cancer treated with radiation therapy." Journal of Clinical Oncology 31, no. 6_suppl (February 20, 2013): 83. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.83.
Full textIsmael, G., A. L. Coradazzi, C. A. Beato, P. Milhomem, J. Oliveira, C. Manzoni, and G. Segalla. "Adjuvant systemic therapy in elderly patients with breast cancer: A Brazilian single center experience." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e20711-e20711. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e20711.
Full textQuon, H. C., P. Cheung, D. A. Loblaw, G. Morton, E. Szumacher, C. Danjoux, R. Choo, G. Thomas, A. Kiss, and A. Deabreu. "Quality of life after pelvic radiotherapy with hypofractionated IMRT boost and long-term hormone therapy for locally advanced prostate cancer." Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 75. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.75.
Full textAngelergues, Antoine, Denis Maillet, Aude Flechon, Mustafa Ozguroglu, Florence Mercier, Aline Guillot, Sylvestre Le Moulec, et al. "Duration of response to androgen-deprivation therapy (ADT) and efficacy of secondary hormone therapy, docetaxel (D), and cabazitaxel (C) in metastatic castration-resistant prostate cancer (mCRPC)." Journal of Clinical Oncology 32, no. 4_suppl (February 1, 2014): 282. http://dx.doi.org/10.1200/jco.2014.32.4_suppl.282.
Full textTsai, Chi-Jui, Ho-Yin Huang, Fang-Ming Chen, Yi-Hsin Yang, Li-Chia Chen, and Kun-Pin Hsieh. "Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ." PLOS ONE 17, no. 1 (January 28, 2022): e0262934. http://dx.doi.org/10.1371/journal.pone.0262934.
Full textBartelink, H., R. D. Rubens, E. van der Schueren, and R. Sylvester. "Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial." Journal of Clinical Oncology 15, no. 1 (January 1997): 207–15. http://dx.doi.org/10.1200/jco.1997.15.1.207.
Full textSella, Tal, and Gabriel Chodick. "Adherence and Persistence to Adjuvant Hormonal Therapy in Early-Stage Breast Cancer Patients: A Population-Based Retrospective Cohort Study in Israel." Breast Care 15, no. 1 (May 29, 2019): 45–54. http://dx.doi.org/10.1159/000500318.
Full textJamy, Omer HASSAN, Namratha Reddy Vontela, Justin Gatwood, Mark Stephen Walker, Edward J. Stepanski, and Gregory A. Vidal. "Using patient-reported outcomes to assess the effectiveness of topical hormonal replacement therapy (THR) for vaginal complaints (VC) after anti-hormonal therapy (HT) treatment for breast cancer (BC)." Journal of Clinical Oncology 34, no. 26_suppl (October 9, 2016): 77. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.77.
Full textSpain, Pamela, Stephanie Teixeira-Poit, Michael T. Halpern, Kathleen Castro, Irene Prabhu Das, Brenda A. Adjei, and Steven Clauser. "NCI Community Cancer Center Program (NCCCP): Understanding why hormonal therapy for breast cancer was considered but not administered." Journal of Clinical Oncology 34, no. 7_suppl (March 1, 2016): 74. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.74.
Full textLee, Anna, Daniel J. Becker, Ariel J. Lederman, Virginia W. Osborn, Meng S. Shao, Andrew T. Wong, David Schwartz, and David Schreiber. "Comparison of Neoadjuvant vs Concurrent/Adjuvant Androgen Deprivation in Men with High-risk Prostate Cancer Receiving Definitive Radiation Therapy." Tumori Journal 103, no. 4 (July 2017): 387–93. http://dx.doi.org/10.5301/tj.5000595.
Full textLoeb, Stacy, Meike Adam, Pierre Tennstedt, Wolfgang Huber, Juergen Bernard, Derya Tilki, Markus Graefen, Hartwig Huland, and Thorsten Schlomm. "Toxicity in a multimodality approach of radical prostatectomy with radiation and hormonal therapy." Journal of Clinical Oncology 34, no. 2_suppl (January 10, 2016): 107. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.107.
Full textGartrell, Benjamin Adam, Giuseppe Del Priore, Avi S. Retter, Wen-Tien Chen, Gerald H. Sokol, Alexander G. Vandell, and Mack Roach. "Evaluating non-hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer." Journal of Clinical Oncology 37, no. 7_suppl (March 1, 2019): 83. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.83.
Full textJerusalem, Guy Heinrich Maria, Patrick Neven, Nina Marinsek, Jie Zhang, Ravi Degun, Giancarlo Benelli, Stephen Saletan, and Fabrice Andre. "Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) in Europe." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e17520-e17520. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e17520.
Full textSitruk-Ware, Regine. "Progestins in hormonal therapy (HT) today, tomorrow and the next day: a roundtable discussion." Steroids 68, no. 10-13 (November 2003): 973–79. http://dx.doi.org/10.1016/j.steroids.2003.08.004.
Full textSansone, Pasquale, Claudia Savini, Ivana Kurelac, Qing Chang, Laura Benedetta Amato, Antonio Strillacci, Anna Stepanova, et al. "Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer." Proceedings of the National Academy of Sciences 114, no. 43 (October 11, 2017): E9066—E9075. http://dx.doi.org/10.1073/pnas.1704862114.
Full textBarata, Pedro C., Hamid Emamekhoo, Prateek Mendiratta, Dharmesh Gopalakrishnan, Vadim S. Koshkin, Allison Janine Tyler, Moshe Chaim Ornstein, et al. "Treatment patterns for metastatic hormone-sensitive prostate cancer (mHSPC) progressing after up-front docetaxel in combination with androgen deprivation therapy (D-ADT)." Journal of Clinical Oncology 36, no. 6_suppl (February 20, 2018): 305. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.305.
Full textTassinari, Roberta, and Francesca Maranghi. "Rodent Model of Gender-Affirming Hormone Therapies as Specific Tool for Identifying Susceptibility and Vulnerability of Transgender People and Future Applications for Risk Assessment." International Journal of Environmental Research and Public Health 18, no. 23 (November 30, 2021): 12640. http://dx.doi.org/10.3390/ijerph182312640.
Full textSantoro, Nanette, Cassandra Roeca, Brandilyn A. Peters, and Genevieve Neal-Perry. "The Menopause Transition: Signs, Symptoms, and Management Options." Journal of Clinical Endocrinology & Metabolism 106, no. 1 (October 23, 2020): 1–15. http://dx.doi.org/10.1210/clinem/dgaa764.
Full textSymmans, William Fraser, Eleni Andreopoulou, Daniel J. Booser, Christos Hatzis, Michael J. Wallace, Ya Zhang, Yun Gong, et al. "Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER+) breast cancer: Relevance to palliative treatment." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 515. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.515.
Full textMoleti, Mariacarla, Maria Di Mauro, Angela Alibrandi, Roberto Vita, Salvatore Benvenga, and Francesco Vermiglio. "Postpartum Thyroiditis in Women With Euthyroid and Hypothyroid Hashimoto’s Thyroiditis Antedating Pregnancy." Journal of Clinical Endocrinology & Metabolism 105, no. 7 (April 17, 2020): e2421-e2428. http://dx.doi.org/10.1210/clinem/dgaa197.
Full textAl-Saleh, Khalid A., Adda Bounedjar, Mohammed Oukkal, Hasen Mahfouf, Kamel Bouzid, Assia Bensalem, Prof Taha Fillali, et al. "Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 594. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.594.
Full textSafronova, E. Yu, A. A. Krasheninnikov, S. A. Sergienko, and A. A. Kostin. "THE USE OF MODERN ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN THE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER." Research'n Practical Medicine Journal 4, no. 2 (June 17, 2017): 23–28. http://dx.doi.org/10.17709/2409-2231-2017-4-2-3.
Full textPortokalidou, Zoi, Anna Huysse-Gaytandjieva, and Madelon L. Peters. "Experiences of Patients With Hashimoto Thyroiditis Through the Lens of Compassion." OBM Integrative and Complementary Medicine 7, no. 3 (January 9, 2022): 1. http://dx.doi.org/10.21926/obm.icm.2203027.
Full textAbdul Sater, Houssein Talal, Ramses F. Sadek, Li fang Zhang, Aaron Gopal, Jean-Pierre Blaize, David Yashar, Reena Patel, Swetha Aribindi, Hiral S. Patel, and Shou-Ching Tang. "Validity of 1% hormonal positivity cutoff by American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines at Georgia Cancer Center." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 1094. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1094.
Full textGoy, Barry W., and In-Lu Amy Liu. "Redefining the role of adjuvant versus salvage radiation therapy for prostate cancer after radical prostatectomy for T3 disease and/or positive margins." Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020): 367. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.367.
Full textJerez, Jose Manuel, Nuria Ribelles, Pablo Rodriguez-Brazzarola, Tamara Diaz Redondo, Begoña Jimenez Rodriguez, Alfonso Sanchez-Muñoz, Antonia Marquez, et al. "Prediction of early progression (EP) to CDKIs first line treatment in ER+/HER2- metastatic breast cancer (MBC) using machine learning." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13040-e13040. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13040.
Full textPalomares, Melanie R., Michelle Banzet, Kelley Lu, Jacob Justus, Rebecca A. Ottesen, and Joyce C. Niland. "Breast cancer risk reduction among patients with DCIS." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1562. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1562.
Full textLadha, Abdullah, and Josy Mathew. "Risk factors for fractures in patients on hormonal therapies for breast cancer and DCIS." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e19627-e19627. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e19627.
Full textKling, Juliana M., N. Maritza Dowling, Heather A. Bimonte-Nelson, Carey E. Gleason, Kejal Kantarci, JoAnn E. Manson, Hugh S. Taylor, et al. "Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 317, no. 6 (December 1, 2019): R912—R920. http://dx.doi.org/10.1152/ajpregu.00234.2019.
Full textSchelbaum, Eva, Lacey Loughlin, Steven Jett, Cenai Zhang, Grace Jang, Niharika Malviya, Hollie Hristov, et al. "Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife." Neurology 97, no. 23 (November 3, 2021): e2328-e2339. http://dx.doi.org/10.1212/wnl.0000000000012941.
Full textMeyer, Nicole, Yanni Hao, Xue Song, Nianwen Shi, William Johnson, Jaqueline Willemann Rogerio, and Denise A. Yardley. "Healthcare Resource Use and Expenditures among Metastatic Breast Cancer Patients Treated with HER2-Targeted Agents." International Journal of Breast Cancer 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/475171.
Full textAggarwal, Sangeeta, Mingfeng Liu, Rishi Sharma, Fred Yang, Ankit Gupta, Divjot Singh, Rahul Sharma, Anirban Basak, and Alok Aggarwal. "Voice of Cancer Patients: Analysis of patient concerns regarding cognitive deficits associated with treatment for breast cancer." Journal of Clinical Oncology 33, no. 28_suppl (October 1, 2015): 82. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.82.
Full textBove, Riley, Liene Elsone, Enrique Alvarez, Nadja Borisow, Melissa M. Cortez, Farrah J. Mateen, Maureen A. Mealy, et al. "Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study." Neurology - Neuroimmunology Neuroinflammation 4, no. 3 (March 24, 2017): e339. http://dx.doi.org/10.1212/nxi.0000000000000339.
Full textRavnik, M., A. Sadikov, N. Snoj, P. Nussdorfer, and T. Cufer. "Validation of Adjuvant!Online on Slovenian collective of early breast cancer patients." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e11532-e11532. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11532.
Full textSinibaldi, V. J., M. A. Carducci, K. Elza-Brown, E. Rosenbaum, S. Denmeade, R. Pili, J. Walczak, E. Garrett-Mayer, S. Moore-Cooper, and M. A. Eisenberger. "A phase II evaluation of imatinib mesylate (G) in stage M0 prostate cancer (PC) patients (pts) on hormonal therapy (HT) with evidence of biochemical relapse." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 14612. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.14612.
Full textMason, Jeremy, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J. Gao, Tatiana M. Prowell, Harpreet Singh, et al. "Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer." JCO Clinical Cancer Informatics, no. 5 (June 2021): 758–67. http://dx.doi.org/10.1200/cci.21.00025.
Full textMattar, André, Guilherme R. Fonseca, Murilo B. A. Romão, Jorge Y. Shida, Vilmar M. de Oliveira, Maria C. S. Bastos, Fabio Bagnoli, et al. "Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil." JCO Global Oncology, no. 7 (July 2021): 1003–11. http://dx.doi.org/10.1200/go.20.00609.
Full textEllis, Peter G., Adam M. Brufsky, Sushil Beriwal, Kathleen G. Lokay, Hans O. Benson, Stephanie B. McCutcheon, and Melinda Krebs. "Pathways Clinical Decision Support for Appropriate Use of Key Biomarkers." Journal of Oncology Practice 12, no. 6 (June 2016): e681-e687. http://dx.doi.org/10.1200/jop.2015.010546.
Full text